Aposhian HV - Search Results

1

Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.

Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Aposhian MM, Dart RC, Woods JS, Ostrosky-Wegman P, Gonsebatt ME, Aposhian HV. Maiorino RM, et al. Among authors: aposhian mm, aposhian hv. J Pharmacol Exp Ther. 1996 May;277(2):938-44. J Pharmacol Exp Ther. 1996. PMID: 8627576

2

Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.

Maiorino RM, Dart RC, Carter DE, Aposhian HV. Maiorino RM, et al. Among authors: aposhian hv. J Pharmacol Exp Ther. 1991 Nov;259(2):808-14. J Pharmacol Exp Ther. 1991. PMID: 1941628

3

Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.

Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhian HV. Hurlbut KM, et al. Among authors: aposhian hv. J Pharmacol Exp Ther. 1994 Feb;268(2):662-8. J Pharmacol Exp Ther. 1994. PMID: 8113976

4

DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.

Aposhian HV, Arroyo A, Cebrian ME, del Razo LM, Hurlbut KM, Dart RC, Gonzalez-Ramirez D, Kreppel H, Speisky H, Smith A, Gonsebatt ME, Ostrosky-Wegman P, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. J Pharmacol Exp Ther. 1997 Jul;282(1):192-200. J Pharmacol Exp Ther. 1997. PMID: 9223554

5

DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.

Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV. Gonzalez-Ramirez D, et al. Among authors: aposhian hv. J Pharmacol Exp Ther. 1998 Oct;287(1):8-12. J Pharmacol Exp Ther. 1998. PMID: 9765315

6

Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score.

Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM, Aposhian MM. Aposhian HV, et al. Among authors: aposhian mm. FASEB J. 1992 Apr;6(7):2472-6. doi: 10.1096/fasebj.6.7.1563599. FASEB J. 1992. PMID: 1563599

7

Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.

Maiorino RM, Akins JM, Blaha K, Carter DE, Aposhian HV. Maiorino RM, et al. Among authors: aposhian hv. J Pharmacol Exp Ther. 1990 Aug;254(2):570-7. J Pharmacol Exp Ther. 1990. PMID: 2166796

8

Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.

Maiorino RM, Aposhian HV. Maiorino RM, et al. Among authors: aposhian hv. Biochem Pharmacol. 1989 Apr 1;38(7):1147-54. doi: 10.1016/0006-2952(89)90261-x. Biochem Pharmacol. 1989. PMID: 2539817

9

Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.

Aposhian HV, Maiorino RM, Dart RC, Perry DF. Aposhian HV, et al. Clin Pharmacol Ther. 1989 May;45(5):520-6. doi: 10.1038/clpt.1989.67. Clin Pharmacol Ther. 1989. PMID: 2541962

10

Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.

Maiorino RM, Aposhian HV. Maiorino RM, et al. Among authors: aposhian hv. Toxicol Appl Pharmacol. 1985 Feb;77(2):240-50. doi: 10.1016/0041-008x(85)90323-0. Toxicol Appl Pharmacol. 1985. PMID: 2983455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters